Supreme Court extends temporary pause on abortion‑pill restrictions through Thursday
On May 12, Justice Samuel Alito granted an emergency extension of a temporary court order that keeps medication abortion pills available by mail nationwide until at least Thursday. The pause follows a Fifth Circuit ruling that had reinstated a requirement for in‑person provider visits, a rule that civil‑rights groups argue would severely limit access for low‑income women.
The decision comes amid a wave of state‑level bans and federal challenges over the FDA‑approved drug regimen. The Supreme Court’s action maintains the status quo while the case, brought by the Center for Reproductive Rights, proceeds toward oral arguments later this year. The issue has been a flashpoint since the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization overturned Roe v. Wade.
According to The Hill, the order was issued without a written opinion, signaling a narrow, procedural relief. Reuters notes that Alito’s extension is unusual for a Justice who has aligned with the Court’s conservative bloc on abortion. Data from the Guttmacher Institute indicates that 2.5 million women have used medication abortions annually, and a return to in‑person mandates could increase travel costs by an average of $850 per patient.
Legal analysts predict that the brief pause may be strategic, allowing the Court to gauge public reaction before a possible full hearing. Professor Anita Lee of Harvard Law School argues that “the Court is buying time to assess whether a nationwide ban would survive constitutional scrutiny given the evolving medical standards.”
The next critical date is the oral argument scheduled for October, after which the Court could issue a definitive ruling that may either uphold or strike down the in‑person requirement. Stakeholders, including state health departments and advocacy groups, will be closely watching for any signals that could reshape abortion access ahead of the 2026 election cycle.